The 2023 IRIS Renal Week will be held from Monday March 20, through Thursday March 23 2023 in Davis CA. Bootcamp will be held on Thursday March 23 through Saturday March 25 2023.
CLICK HERE for registration details
Rebecca Geddes is the recipient of the 2022 IRIS Early Career Award
The winner of the 2022 IRIS Award (Early Career Award) was Dr. Rebecca Geddes, MA, VetMB, GPCert(FelP), MVetMed, PhD, DipACVIM, MRCVS. The award, sponsored by Zoetis, consists of a prize of 10000 euros and travel to a conference to receive the prize and give a lecture. The presentation was made at the 2022 ECVIM conference in Gothenburg, Sweden. Dr. Geddes’ work has centered around the regulation of calcium and phosphate – and how this is deranged in cats with CKD. In particular she has shown the prognostic importance of the phosphate-lowering hormone, fibroblast growth factor-23 (FGF-23), and that elevated concentrations of this hormone can serve as an indicator of increased phosphate load within the body, and the requirement for dietary therapy to address this.
Congratulations Dr Geddes!
Stephen DiBartola to receive 2019 Osborne Award for Veterinary Nephrology
The 2019 IRIS Osborne Award, generously sponsored by Elanco Animal Health, is to be awarded to Dr. Stephen DiBartola in recognition of his career-spanning contributions to the field of veterinary nephrology.
The International Renal Interest Society (IRIS) was created in 1998 to advance the scientific understanding of kidney disease in small animals. The IRIS board currently consists of 15 members representing 11 different countries. The Osborne Award is the top honour bestowed by the group and there have been only 5 previous recipients: Carl Osborne (1999), Delmar Finco (2000), Kenneth Bovee (2002), Donald Low (2004) and George Lees (2011). The award consists of a plaque and a cheque for $15000 generously supported by Elanco Animal Health. The award winner is also funded to attend ACVIM and/or ECVIM Congresses to receive their award and present an overview of their research. Dr DiBartola’s award is to be presented at the ACVIM Forum in Pheonix, Arizona, in June this year.
Dr DiBartola is these days perhaps best known for his long-serving editorship of the Journal of Veterinary Internal Medicine and for the reference textbook “Fluid, Electrolyte, and Acid Base Disorders in Small Animal Practice”, which is commonly referred to by residents and faculty simply as ‘DiBartola’. However, his contributions to veterinary nephrology have been outstanding including 105 scientific, peer-reviewed publications, 82 book chapters and 21 abstracts. His nephrology publications have increased our understanding of polycystic kidney disease in Persian cats, muscle potassium content in cats with CKD, renal amyloidosis in Chinese Shar pei dogs and Abyssinian cats, dietary-induced CKD in dogs and cats, juvenile renal disease in Standard Poodles and Doberman pinscher dogs, as well as renal tubular acidosis.
On hearing that he was to receive the award Dr DiBartola responded with the following remarks: “I can't tell you how humbling it is to have been nominated for and receive this award - the list of my colleagues who have received it before me is the family tree of veterinary nephrology and I've known all of them personally. I'm old enough to remember reading the first edition of Osborne, Low and Finco's Canine and Feline Urology (published in 1972) cover to cover when I was a veterinary student. However, as is widely known to my colleagues, it is Dennis Chew I have to thank for my career in the field. He was, is and always will be a huge inspiration to me.”
Further details about the work of IRIS can be found here: http://www.iris-kidney.com/index.htmland for further details of the award, please contact Harriet Syme hsyme@rvc.ac.uk, chair of the IRIS Awards Committee. Learn more about Elanco at www.elanco.com.
European College of Veterinary Pharmacology and Toxicology
& European Society of Veterinary Nephrology and Urology
Symposium: Pharmacology and the Kidney
Date: Friday 19th July 2019 Time: 9.00-5.30pm
Venue: Royal Veterinary College, Camden, London, NW1 0TU
Highlights from 2018 IRIS Renal Week
http://www.vetmed.ucdavis.edu/ce/symposia_and_events/small_animal/iris_renal_week_2018.cfm
The University of California-Davis hosted the 7th IRIS Renal Week from March 19th to March 24th. This was an exciting conference that has dramatically evolved and grown since its inception in 2004. This year’s conference boasted over 160 attendees (50% were international), as well as lectures and labs from leaders in the field of veterinary nephrology and urology.
Highlights from this year’s conference include:
· A 2-day boot camp comprised of lectures and labs designed to teach and demonstrate principles and integration of extracorporeal therapies. Over 70 attendees participated.
· A lecture series focusing on new insights into the understanding and management of glomerular disease in dogs in cats. This included an update on the WSAVA Renal Classification Project, a presentation on the increasing awareness of Focal Segmental Glomerulosclerosis (FSGS) in animals, and intriguing discussions regarding changes in patterns for the management of canine glomerular disease in dogs, both in terms of which drugs to use and when to perform renal biopsies.
· An exciting session on the latest advances in veterinary extracorporeal therapies. There were presentations on two new and innovative, commercially available synthetic filters for the use of hemoadsorption and hemoperfusion, including one that can remove cytokines in patients with sepsis and septic shock. There was also a discussion regarding the use of therapeutic plasma exchange as a first-line therapy for cases of severe or refractory IMHA in dogs.
· A renewed look at hypertension, it’s prevalence in differing patterns of glomerular disease, the use of biomarkers in feline hypertension, and an evidence-based comparison of the antihypertensive effects of telemisartan and amlodipine.
· An update on the latest biomarkers in nephrology and urology. This included both novel biomarkers for the diagnosis and monitoring of AKI and CKD, as well as the resurrection of the urine sediment as an important diagnostic tool.
· A re-evaluation of clinical significance of bacteriuria, primarily with regards to the acknowledgement of subclinical bacteriuria in veterinary medicine. There was also a preview of the updated International Society for Companion Animal Infectious Disease (ISCAID) Urinary Tract Infection Guidelines, which recommends a more conservative approach of antibiotics than what has previously been recommended as standard of care.
· A new initiative for “One Health Nephrology” was proposed and highlighted throughout the conference, with lectures from keynote speakers in both human and veterinary nephrology.
Thanks for all involved in the organization of such an outstanding meeting! Stay tuned for IRIS Renal Week 2020!